Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Etiology and Outcome of Inflammatory Bowel Disease
Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is characterized by chronic inflammation of gastrointestinal tract.
In 2015, approximately three million US adults reported having a diagnosis of IBD and the estimated number has increased greatly
from 1. 8 million since 199 9. While the exact cause is unknown, the severity and progression of the disease largely impacts the patients’ quality of life and imposes huge financial burden to the US healthcare system.
The purpose of this announcement is to 1) establish a new IBD registry to estimate incidence of IBD in the adult and pediatric populations and extrapolate to the US population; 2) describe the natural history and outcomes of IBD; 3) determine racial/ethnic variation in the detection and management of IBD; and 4) identify evidence-based strategies to improve disease outcomes.
The results are anticipated to enhance understanding of the impact of IBD on the overall health of affected persons and the impact of various clinical practices and healthcare delivery approaches on the disease outcomes.
In 2015, approximately three million US adults reported having a diagnosis of IBD and the estimated number has increased greatly
from 1. 8 million since 199 9. While the exact cause is unknown, the severity and progression of the disease largely impacts the patients’ quality of life and imposes huge financial burden to the US healthcare system.
The purpose of this announcement is to 1) establish a new IBD registry to estimate incidence of IBD in the adult and pediatric populations and extrapolate to the US population; 2) describe the natural history and outcomes of IBD; 3) determine racial/ethnic variation in the detection and management of IBD; and 4) identify evidence-based strategies to improve disease outcomes.
The results are anticipated to enhance understanding of the impact of IBD on the overall health of affected persons and the impact of various clinical practices and healthcare delivery approaches on the disease outcomes.
Related Programs
Assistance Programs for Chronic Disease Prevention and Control
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $3,250,000
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $3,250,000
Who's Eligible
Obtain Full Opportunity Text:
Office of Elementary and Secondary Education (OESE): Small, Rural School Achievement Program CFDA Number 84358A; Application Deadline for Fiscal Year (FY) 2012
Additional Information of Eligibility:
None
Full Opportunity Web Address:
http://www.gpo.gov/fdsys/pkg/FR-2012-04-23/pdf/2012-9746.pdf
Contact:
Agency Email Description:
Grants Policy
Agency Email:
Date Posted:
2017-11-30
Application Due Date:
Archive Date:
2018-03-11
Social Entrepreneurship
Spotlight
Building a Million Dollar Company Where Everyone Counts
Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.
Learn How to Identify and Avoid Grant Scams
